Biomechanical Insights into the Proteomic Profiling of Cells in Response to Red Light Absorption
Small · 2025
DOI: 10.1002/smll.202410062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Antônio V S Silva und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Física, Universidade Federal do Ceará, Fortaleza, CE, 60440-900, Brazil. Hauptthemen laut MEDLINE: Proteomics, Light. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: CAPES, CNPq, FUNCAP.
Abstract (Originalsprache)
Photobiomodulation (PBM) is a promising non‐invasive therapy for tissue repair, but its underlying cellular mechanisms are not fully understood. In this study, the biomechanical and proteomic responses of three cell types – keratinocytes (HACAT), fibroblasts (L929), and osteoblasts (OFCOLII) – exposed to red light (633 nm) are investigated using atomic force microscopy (AFM) and mass spectrometry‐based proteomic analysis. Red light absorption resulted in cell‐type‐specific changes in viscoelastic properties, with fibroblasts exhibiting increased fluidity, reduced stiffness, and enhanced motility. Conversely, keratinocytes exhibited intensity‐dependent responses, while osteoblasts appeared to be relatively insensitive to irradiation conditions. Proteomic profiling identified key signaling pathways involved in immune response, ATP production, and stress regulation. The immune and ATP pathways are strongly linked to the modulation of viscoelastic properties, particularly in fibroblasts, while weaker correlations were observed in keratinocytes. Cytoskeletal remodeling, primarily within the F‐actin network, is identified as the main driver of mechanical alterations, with additional contributions from microtubules and intermediate filaments. These findings provide new insights into how red light absorption modulates cellular viscoelasticity through cytoskeletal remodeling, with potential applications in optimizing light‐based therapies for tissue regeneration and disease treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Física, Universidade Federal do Ceará, Fortaleza, CE, 60440-900, Brazil.
- Instituto Federal do Rio Grande do Norte, Pau dos Ferros, RN, 59900-000, Brazil.
- Núcleo de Biologia Experimental, Universidade de Fortaleza, Fortaleza, CE, 60811-905, Brazil.
- Departamento de Bioquímica e Biologia Molecular, Universidade Federal do Ceará, Fortaleza, CE, 60440-900, Brazil.
- Departamento de Biologia, Universidade Federal do Ceará, Fortaleza, CE, 60440-900, Brazil.
- Departamento de Fisiologia e Farmacologia, Universidade Federal do Ceará, Fortaleza, CE, 60430-275, Brazil.
ORCID-Profile: Jeanlex S de Sousa
Förderung
- CAPES
- CNPq
- FUNCAP
- Fundação Edson Queiroz
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico
Zitieren
APA
Silva, A. V. S., Sousa, F. D., Sousa, B. F., Santos, W. V., Oliveira, A. E. R., Lobo, M. D. P., Ramos, M. V., Alencar, N. M. N., de Sousa, M. V. P., Freire, R. S., Oliveira, C. L. N., & de Sousa, J. S. (2025). Biomechanical Insights into the Proteomic Profiling of Cells in Response to Red Light Absorption. Small. https://doi.org/10.1002/smll.202410062
Vancouver
Silva AVS, Sousa FD, Sousa BF, Santos WV, Oliveira AER, Lobo MDP, et al. Biomechanical Insights into the Proteomic Profiling of Cells in Response to Red Light Absorption. Small. 2025. doi:10.1002/smll.202410062
BibTeX
@article{Silva2025,
author = {Silva, Antônio V S and Sousa, Felipe D and Sousa, Brandon F and Santos, Wallace V and Oliveira, Antônio E R and Lobo, Marina D P and Ramos, Márcio V and Alencar, Nylane M N and de Sousa, Marcelo V P and Freire, Rosemayre S and Oliveira, Cláudio L N and de Sousa, Jeanlex S},
title = {Biomechanical Insights into the Proteomic Profiling of Cells in Response to Red Light Absorption},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202410062}
}
EUVIMED